BNKL (Bionik Laboratories) FCF Margin %: -151.10% (As of Mar. 2023)


BNKL Bionik Laboratories Corp BNKL
12 GF Score
Price $0.00
View Full Analysis

What is Bionik Laboratories FCF Margin %?

Bionik Laboratories BNKL -99.00% 12 FCF Margin % is -151.10% as of Mar. 2023. GuruFocus rates BNKL with a GF Score™ of 12/100.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bionik Laboratories's Free Cash Flow for the three months ended in Mar. 2023 was $-0.76 Mil. Bionik Laboratories's Revenue for the three months ended in Mar. 2023 was $0.50 Mil. Therefore, Bionik Laboratories's FCF Margin % for the quarter that ended in Mar. 2023 was -151.10%.

As of today, Bionik Laboratories's current FCF Yield % is 0.00%.

The historical rank and industry rank for Bionik Laboratories's FCF Margin % or its related term are showing as below:

BNKL' s FCF Margin % Range Over the Past 10 Years
Min: -187.65   Med: 0   Max: 0
Current: -187.65

BNKL's FCF Margin % is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 3.1 vs BNKL: -187.65

Bionik Laboratories FCF Margin % Related Terms

Bionik Laboratories FCF Margin % Historical Data

* Premium members only.

The historical data trend for Bionik Laboratories's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories FCF Margin % Chart

Bionik Laboratories Annual Data
Trend Dec14 Dec15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -287.55 -428.43 -387.59 -326.53 -187.65

Bionik Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -722.51 -478.19 -196.50 -89.22 -151.10

BNKL vs ARPC, GRST, IONM: FCF Margin % Comparison

For the Medical Care Facilities subindustry, Bionik Laboratories's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionik Laboratories FCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bionik Laboratories's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bionik Laboratories's FCF Margin % falls into.


BNKL
12GF Score
Bionik Laboratories Corp BNKL
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bionik Laboratories FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bionik Laboratories's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-3.387/1.805
=-187.65 %

Bionik Laboratories's FCF Margin for the quarter that ended in Mar. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=-0.757/0.501
=-151.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -151.10% mean?
Bionik Laboratories (BNKL) has a FCF Margin % of -151.10% as of Mar. 2023. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bionik Laboratories and its competitors.
Is Bionik Laboratories' FCF Margin % too high?
Bionik Laboratories' current FCF Margin % is -151.10%. Overall, Bionik Laboratories has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bionik Laboratories' FCF Margin % compare to ARPC and GRST?
Bionik Laboratories' FCF Margin % of -151.10% can be compared against companies in the Healthcare Providers & Services industry. The industry median FCF Margin % is 3.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.10, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bionik Laboratories and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bionik Laboratories's current FCF Margin % is -151.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionik Laboratories stock overvalued right now?
Bionik Laboratories (BNKL) has a current FCF Margin % of -151.10%. The current FCF Margin % is -151.10%. Bionik Laboratories' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Bionik Laboratories (BNKL), the current FCF Margin % is -151.10% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionik Laboratories Business Description

Address 80 Coolidge Hill Road, Watertown, MA, USA, 02472
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
12GF Score

Get the complete analysis for BNKL

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price